Calcium antagonists are effective for managing angina in patients with coronary artery disease, with specific agents like nifedipine, verapamil, or diltiazem chosen based on patient comorbidities.
Calcium antagonists provide specific therapeutic advantages in managing angina depending on the presence of comorbidities like heart block, hypertension, or supraventricular tachycardia.
At present nitrates remain the initial treatment for relief or prevention of angina in patients with coronary artery disease. In cases where nitrates and beta blockers have been used and are ineffective for managing effort angina, calcium antagonists may be substituted or added to the beta-blocking treatment. When the predominant symptom is rest angina, and there is evidence suggesting coronary artery spasm, nitrates and a calcium antagonist can be effective therapy. In patients with heart block, bradyarrhythmias, heart failure, or hypertension nifedipine may be the drug of choice. In contrast verapamil merits choice when supraventricular tachycardia is present. Diltiazem appears intermediate between nifedipine and verapamil and may be particularly useful when hypotension or other side effects must be avoided.
Pepine et al. (2008) conducted a review in Coronary artery disease and angina. Calcium antagonists (nifedipine, verapamil, diltiazem) was evaluated. Calcium antagonists are effective for managing angina in patients with coronary artery disease, with specific agents like nifedipine, verapamil, or diltiazem chosen based on patient comorbidities.